Evaluation of metformin in combination with rifampicin containing antituberculosis therapy in patients with new, smear-positive pulmonary tuberculosis (METRIF): study protocol for a randomised clinical trial

INTRODUCTION: Shorter duration of treatment for the management of drug-susceptible pulmonary tuberculosis (TB) would be a significant improvement in the care of patients suffering from the disease. Besides newer drugs and regimens, other modalities like host-directed therapy are also being suggested...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMJ Open
Main Authors: Padmapriyadarsini, Chandrasekaran, Bhavani, Perumal K, Natrajan, Mohan, Ponnuraja, Chinnayan, Kumar, Hemanth, Gomathy, Sivaramakrishnan N, Guleria, Randeep, Jawahar, Shaheed M, Singh, Manjula, Balganesh, Tanjore, Swaminathan, Soumya
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2019
Assuntos:
Respiratory Medicine
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6429929/
https://ncbi.nlm.nih.gov/pubmed/30826761
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2018-024363
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados